Sponsor
The TAILORx clinical trial is sponsored by the National Cancer Institute’s program for the Assessment of Clinical Cancer Tests (PACCT-1) and administered by the Eastern Cooperative Oncology Group (ECOG).
All of the NCI-sponsored clinical trial groups that perform breast cancer research have collaborated in the trial's development and are participating in this study. They include:
- The Eastern Cooperative Oncology Group (ECOG)
- The Southwest Oncology Group (SWOG)
- The North Central Cancer Treatment Group (NCCTG)
- The Cancer and Leukemia Group B (CALGB)
- The American College of Surgeons Oncology Group (ACOSOG)
- The National Surgical Breast and Bowel Project (NSABP)
- National Cancer Institute of Canada (NCIC)
|
 |
|
